Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pterosaurs ate soft-bodied cephalopods (Coleoidea).
Scientific reports·2020
Preoperative assessment and classification of benign laryngotracheal stenosis: a consensus paper of the European Laryngological Society.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2015
Accelerated split-course radiation and simultaneous chemotherapy in patients with unresectable head and neck-cancer.
International journal of oncology·2011
Interphase M-FISH applications using commercial probes in prenatal and PGD diagnostics.
Cytogenetic and genome research·2006
Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1.
Biochemical and biophysical research communications·2004
Results of neutron therapy of soft-tissue sarcomas.
Strahlentherapie·1985
Results of curative pion therapy at SIN.
Strahlentherapie·1985
The RENT-project: radiobiological results and planned clinical application.
Strahlentherapie·1985
Neutron and neutron boost irradiation of soft tissue sarcomas.
Strahlentherapie·1985
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026